Quarterly Statement Of Cash Flows

PhoenixBio Co.,Ltd. - Filing #7373608

Concept As at
2023-09-30
2023-04-01 to
2023-09-30
As at
2023-03-31
As at
2022-09-30
2022-04-01 to
2022-09-30
As at
2022-03-31
Quarterly statement of cash flows
Statement of cash flows
Cash flows from operating activities
Profit (loss) before income taxes
63,154,000 JPY
403,383,000 JPY
Depreciation
11,782,000 JPY
11,301,000 JPY
Interest expenses
972,000 JPY
2,120,000 JPY
Foreign exchange losses (gains)
-26,308,000 JPY
-27,991,000 JPY
Decrease (increase) in inventories
-58,863,000 JPY
-41,613,000 JPY
Increase (decrease) in trade payables
-8,492,000 JPY
-10,030,000 JPY
Other, net
62,601,000 JPY
-33,240,000 JPY
Subtotal
4,265,000 JPY
37,964,000 JPY
Interest and dividends received
2,608,000 JPY
326,000 JPY
Interest paid
-972,000 JPY
-2,120,000 JPY
Income taxes paid
-42,978,000 JPY
-4,183,000 JPY
Net cash provided by (used in) operating activities
-33,164,000 JPY
38,681,000 JPY
Cash flows from investing activities
Purchase of property, plant and equipment
-20,769,000 JPY
-1,007,000 JPY
Purchase of investment securities
-8,838,000 JPY
JPY
Other, net
520,000 JPY
53,000 JPY
Net cash provided by (used in) investing activities
124,312,000 JPY
-2,802,000 JPY
Cash flows from financing activities
Net cash provided by (used in) financing activities
19,646,000 JPY
-29,081,000 JPY
Effect of exchange rate change on cash and cash equivalents
56,572,000 JPY
71,399,000 JPY
Net increase (decrease) in cash and cash equivalents
167,367,000 JPY
78,197,000 JPY
Cash and cash equivalents
1,722,690,000 JPY
1,555,323,000 JPY
1,403,704,000 JPY
1,325,507,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.